2020-04-13
Due mainly to the shortcomings of conventional vaccines such as their failure to engage the immune system, low stability in vivo, high toxicity, invasive administration, and the issue of their storage and transport at a certain temperature, researchers have recently turned their attention to nanovaccines, for they greatly help address many of the challenges; especially these days that...
